Overview
| Name | HelixFold-S1 · aliases: HelixFold-S1 |
|---|---|
| Full name | No separate expanded name |
| Ambiguous names (not auto-linked) | HelixFold |
| Family | Not a family entry. Single-model entry, not a family |
| Organization | Baidu |
| Organization type | Big-tech lab |
| Country | China |
| Model class | Contact-guided sampling method |
| Domain | Structure & co-folding |
| First release | † partly verified · preprint Basis: arXiv 2507.09251 v1 (per the earlier record; only the v3 date was verified) source |
| Other milestones | |
| Latest update | · paper revision Basis: arXiv v3 revision arXiv v3 revision, after journal online publication on 2026-07-02; code and weights still not confirmed released source The most recent sourced event, not a claim that nothing changed since. |
| Status | Active · Journal publication and paper revision within 12 months |
| Openness | Code: Closed Weights: Closed Code and weights promised after acceptance but not seen released; an online service is available |
| Benchmarks reported | 0 counted · none of the 44 |
| Wet-lab validation | None recorded |
| Unverified fields | † first_release, release_milestones.journal_online |
| As of | 2026-11-16 |
What it does
Not a new base model but a sampling method on top of HelixFold3: it first predicts inter-chain contacts, then samples likely interfaces, reaching comparable accuracy with far fewer samples.
Benchmarks reported
None of the 44 benchmarks. This model is on the zero-pairing list.
How it evaluates itself: Self-built PDB interface sets; Sampling efficiency
Other evaluations (outside the 44)
- Self-built PDB interface sets (Own task set) Self-reported: Post-2021 PDB complexes: antibody-protein 221, protein-protein 198, ligand 238, RNA 177, DNA 254
- Sampling efficiency (Comparison against baselines only) Self-reported: Compared with baselines on 74 antibody complexes at about one-tenth the sampling
Developers report: Developers report contact-guided sampling gives higher interface accuracy at about one-tenth the sampling, with the largest gain on antibody-antigen interfaces
Independent evidence: No independent evidence found. No independent evidence found
Training data
Group in Figure 7: Public data only.
| Class | Value | Detail |
|---|---|---|
| a. Public databases | Yes | PDB entries before 2021-09-30 plus structure-database distillation data; antibody data from SAbDab |
| b. Private or licensed data | No | |
| c. Own wet-lab data used for training | No | |
| d. Wet lab used only for validation | No |
Wet-lab validation
None. The developers report no wet-lab validation.
Background
- Organization: A biocomputing team at Baidu, built on its own deep-learning framework, internally funded; headcount not disclosed
- Funding: Not disclosed or not applicable
- Products and partnerships: The same team also built HelixFold3 and two design platforms; no HelixFold4 found
- Related models: AlphaFold 3
Reading notes
- All evaluations are self-built PDB subsets outside the 44 benchmarks; on the zero-pairing list under this round's rules
- Code and weights are unreleased, so the sampling-efficiency claim cannot be reproduced externally
Caveats
- Neither the arXiv v1 date nor the journal online date is fully verified
- It is a method, not a base model; not directly comparable with co-folding models
Sources
- arXiv preprint 2507.09251 (preprint)
- Journal article DOI 10.1038/s42256-026-01264-2 (journal)
Corrections
1 correction
| Field | Was | Now | Basis | Found |
|---|---|---|---|---|
| latest_update.event_kind | Journal publication | Paper revision; the journal event is listed separately under 2026-07-02 | source | 2026-11-16 |
Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-16.